Aethlon Medical entered a Securities Purchase Agreement on July 6, 2026, to sell 263,000 shares of common stock, plus roughly 11 million warrants (common and pre-funded) and 225,320 placement agent warrants in a public offering raising approximately $4 million. The placement agent, Maxim Group, received a 6.25% cash fee and warrants. Net proceeds were about $3.335 million for working capital.
View Full Filing (SEC EDGAR)